133 related articles for article (PubMed ID: 2565239)
1. Nebivolol is devoid of intrinsic sympathomimetic activity.
Janssens WJ; Van de Water A; Xhonneux R; Reneman RS; Van Nueten JM; Janssen PA
Eur J Pharmacol; 1989 Jan; 159(1):89-95. PubMed ID: 2565239
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist.
Van de Water A; Janssens W; Van Neuten J; Xhonneux R; De Cree J; Verhaegen H; Reneman RS; Janssen PA
J Cardiovasc Pharmacol; 1988 May; 11(5):552-63. PubMed ID: 2455841
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of nebivolol.
Janssens WJ
J Pharm Belg; 1992; 47(4):323-7. PubMed ID: 1357130
[TBL] [Abstract][Full Text] [Related]
4. The l-enantiomer of nebivolol potentiates the blood pressure lowering effect of the d-enantiomer.
Xhonneux R; Wouters L; Reneman RS; Janssen PA
Eur J Pharmacol; 1990 Jun; 181(3):261-5. PubMed ID: 1974517
[TBL] [Abstract][Full Text] [Related]
5. Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
Ignarro LJ
Cardiovasc Ther; 2008; 26(2):115-34. PubMed ID: 18485134
[TBL] [Abstract][Full Text] [Related]
6. Effects of the selective beta 1-adrenoceptor antagonist, nebivolol, on cardiovascular parameters in the pithed normotensive rat.
Schneider J; Fruh C; Wilffert B; Peters T
Pharmacology; 1990; 40(1):33-41. PubMed ID: 1970437
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the sympatholytic action of nebivolol and hypotension.
Ward JE; Coles P; Cox H; Eisenhofer G; Angus JA
J Cardiovasc Pharmacol; 1992 Jul; 20(1):115-24. PubMed ID: 1383620
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
Brixius K; Bundkirchen A; Bölck B; Mehlhorn U; Schwinger RH
Br J Pharmacol; 2001 Aug; 133(8):1330-8. PubMed ID: 11498519
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of nebivolol.
Mangrella M; Rossi F; Fici F; Rossi F
Pharmacol Res; 1998 Dec; 38(6):419-31. PubMed ID: 9990650
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats.
Toblli JE; Cao G; Casas G; Mazza ON
Am J Hypertens; 2006 Dec; 19(12):1226-32. PubMed ID: 17161767
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivolol.
Kuroedov A; Cosentino F; Lüscher TF
Cardiovasc Drug Rev; 2004; 22(3):155-68. PubMed ID: 15492765
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of dl-nebivolol and its enantiomers--a comparison with those of atenolol.
Van de Water A; Xhonneux R; Reneman RS; Janssen PA
Eur J Pharmacol; 1988 Oct; 156(1):95-103. PubMed ID: 3208842
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
De Crée J; Cobo C; Geukens H; Verhaegen H
Angiology; 1990 Feb; 41(2):95-105. PubMed ID: 1968323
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with nebivolol improves arterial reactivity and reduces ventricular hypertrophy in spontaneously hypertensive rats.
Guerrero E; Voces F; Ardanaz N; Montero MJ; Arévalo M; Sevilla MA
J Cardiovasc Pharmacol; 2003 Sep; 42(3):348-55. PubMed ID: 12960679
[TBL] [Abstract][Full Text] [Related]
15. Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
Bundkirchen A; Brixius K; Bölck B; Schwinger RH
J Pharmacol Exp Ther; 2002 Mar; 300(3):794-801. PubMed ID: 11861783
[TBL] [Abstract][Full Text] [Related]
16. Effect of nebivolol on beat-to-beat and short-term blood pressure variability in spontaneously hypertensive rats.
Bertera FM; Del Mauro JS; Polizio AH; Chiappetta D; Taira CA; Höcht C
Naunyn Schmiedebergs Arch Pharmacol; 2012 Aug; 385(8):833-43. PubMed ID: 22566167
[TBL] [Abstract][Full Text] [Related]
17. Does nebivolol influence serum concentrations of proinflammatory cytokines in hypertensive (SHR) and normotensive (WKY) rats?
Górska D; Dudarewicz M; Czarnecka E; Andrzejczak D
Pharmacol Rep; 2010; 62(1):86-94. PubMed ID: 20360618
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of nebivolol at rest and on exertion in patients with heart failure.
Brune S; Schmidt T; Tebbe U; Kreuzer H
Angiology; 1990 Sep; 41(9 Pt 1):696-701. PubMed ID: 1977335
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of intracerebroventricular injections of (+/-)-nebivolol and its enantiomers--a comparison with those of metoprolol in the rat.
Midol-Monnet M; Davy M; Heimburger M; Beslot F; Cohen Y
J Pharm Pharmacol; 1991 Jul; 43(7):504-9. PubMed ID: 1682465
[TBL] [Abstract][Full Text] [Related]
20. Adrenoceptor blocking hemodynamic and coronary effects of YM-09538, a new combined alpha- and beta-adrenoceptor blocking drug, in anesthetized dogs.
Takenaka T; Asano M; Berdeaux A; Giudicelli JF
Eur J Pharmacol; 1982 Nov; 85(1):35-50. PubMed ID: 6129981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
